FDA / EUA APPROVED
The test helps fill an urgent need across the U.S. for hospitals to access an easy-to-use, rapid diagnostic test to screen patients and health care workers for COVID-19.
SIMPLE & EFFICIENT
Complete test in one tube
SENSITIVE & COST EFFECTIVE
Fully automated to simplify workflow
BioGX SARS-CoV-2 Reagents for BD MAX™
BioGX SARS-CoV-2 Reagents for BD MAX™ is a real-time reverse transcriptase, polymerase chain reaction (PCR) assay for use on the BD MAX™ platform for the qualitative detection of the presence of RNA from nucleocapsid phosphoprotein gene (N gene) of the SARS-CoV-2 coronavirus and the human RNase P gene. The primer and probe sets are based on the United States Centers for Disease Control and Prevention (US CDC) assay for specific detection of SARS-CoV-2 by amplifying two unique regions of the N gene (i.e., N1 and N2).
The majority of BD MAX™ Systems are installed in hospital laboratories, reducing the added time and complexity of needing to send samples to a reference lab. The system is fully automated, reducing the opportunity for human error and increasing the speed to result. The BD MAX™ System can process 24 samples simultaneously.
The BioGX SARS-CoV-2 Reagents for the BD MAX™ System is available for purchase via Becton, Dickinson and Company directly. For more information, please contact [email protected].
- Single lyophilized tube minimizes set- up time
- Time-to-result: <2 hours for 24 samples
- Increase hands-free time with the fully automated BD MAX™
- Scalable workflow allows you to run a single sample or batches of up to 24 samples.
- Quality: EUA (Emergency Use Authorization)
- Cost Effective
Contact us for more information about BioGX SARS-CoV-2 Reagents